Trigeminal Nerve Diseases: Clinical Trials

13 trials for Trigeminal Nerve Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 recruiting, 3 unknown, 2 terminated. 13 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 113Completed 4, Recruiting 3, Unknown 3, Terminated 2, Withdrawn 1
Phase 25Unknown 2, Completed 1, Recruiting 1, Terminated 1

Follow Trigeminal Nerve Diseases: new trials by email Literature Review of Trigeminal Nerve Diseases trials Research Report on Trigeminal Nerve Diseases

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RP-008 in Combination With Daily Oral Varenicline for the Treatment of Trigeminal Neuralgia
RP-008, Varenicline tartrate - Trigeminal Neuralgia
Phase 1 / Phase 2RecruitingKriya Therapeutics, Inc.242026-09-102026-10-23
Deep Brain Stimulation for Refractory Trigeminal Neuralgia with a Pontine Lesion
Deep brain stimulation - Trigeminal Neuralgia
Phase 1RecruitingUniversité de Sherbrooke62024-10-152024-12-12
Risk of Nerve Damage After Administration of Local Anesthesia
4% Articaine with 1:200,000 epinephrine, 2% lidocaine with 1:100,000 epinephrine - Inferior Alveolar Nerve Injuries
Phase 1UnknownCleveland Dental Institute802024-01-012024-08-26
Paresthesia-free Peripheral Nerve Field Stimulation for Trigeminal Neuralgia (FreeST Trial)
Paresthesia-free Peripheral Nerve Field Stimulation, Sham stimulation - Trigeminal Neuralgia, Facial Pain
Phase 1 / Phase 2UnknownUniversity Health Network, Toronto242022-10-282024-02-23
Safety of Cultured Allogeneic Adult Umbilical Cordor Placental Derived Stem Cells Exosomes for Trigeminal Neuralgia
cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cell exosomes - Peripheral Neuropathy, Trigeminal Neuralgia
Phase 1RecruitingThe Foundation for Orthopaedics and Regenerative Medicine202022-09-092026-10-20
Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache
Ketorolac, Dexamethasone - Chronic Migraine, Cluster Headache
Phase 1WithdrawnWeill Medical College of Cornell University2020-10-012020-08-04
New Formulation and Food Effect Study of BIIB074
BIIB074 Treatment A, BIIB074 Treatment B, BIIB074 Treatment C - Trigeminal Neuralgia (TN), Other Neuropathic Pain
Phase 1CompletedBiogen282016-12-012017-02-27
PK and Safety Study of BIIB074 in Healthy Japanese and Caucasian Participants
BIIB074, Placebo - Healthy, Trigeminal Neuralgia
Phase 1CompletedBiogen642016-08-012017-03-09
Glycerol Block of the Trigeminal Ganglion in Trigeminal Neuralgia Using a New Neuronavigation-based Surgical Technique
Glycerol - Trigeminal Neuralgia, Headache Disorders
Phase 1 / Phase 2TerminatedNorwegian University of Science and Technology12016-05-012019-03-27
Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues.
Botulinum Toxin Type A - Trigeminal Neuralgia, Headache Disorders
Phase 1 / Phase 2CompletedNorwegian University of Science and Technology102016-05-012019-07-29
PK & Tolerability of CNV1014802 in Young and Elderly Healthy Volunteers
CNV1014802, Placebo - Trigeminal Neuralgia
Phase 1CompletedBiogen322015-02-032017-10-12
Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.
Epidural Motor Cortex Stimulation - Trigeminal Neuralgia (Burchiel Type I), Trigeminal Neuralgia (Burchiel Type II)
Phase 1TerminatedJohns Hopkins University12015-02-012019-02-18
Clinical Trial of Hyperbaric Oxygen Treatment in Trigeminal Neuralgia Patients
Hyperbaric oxygen, Mock hyperbaric chamber - Trigeminal Neuralgia, Pain
Phase 1 / Phase 2UnknownXijing Hospital302008-04-012009-03-20

Narrower conditions

Trigeminal Neuralgia (12)  ·  Headache Disorders (2)  ·  Cluster Headache (1)  ·  Complex Regional Pain Syndromes (1)  ·  Facial Pain (1)  ·  Glossopharyngeal Nerve Diseases (1)  ·  Mandibular Nerve Injuries (1)  ·  Multiple Sclerosis (1)  ·  Pain (1)  ·  Peripheral Nervous System Diseases (1)

Broader conditions

Cranial Nerve Diseases (13)  ·  Facial Nerve Diseases (13)  ·  Facial Neuralgia (13)  ·  Mouth Diseases (13)  ·  Nervous System Diseases (13)  ·  Stomatognathic Diseases (13)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Neurologic Manifestations (2)  ·  Neuromuscular Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)

Interventions

vixotrigine (2)  ·  Botulinum Toxins, Type A (1)  ·  Carticaine (1)  ·  Deep Brain Stimulation (1)  ·  Dexamethasone (1)  ·  Epinephrine (1)  ·  Glycerol (1)  ·  Ketorolac (1)  ·  Lidocaine (1)  ·  Varenicline (1)

Sponsors

Biogen (3)  ·  Norwegian University of Science and Technology (2)  ·  Cleveland Dental Institute (1)  ·  Johns Hopkins University (1)  ·  Kriya Therapeutics, Inc. (1)  ·  The Foundation for Orthopaedics and Regenerative Medicine (1)  ·  University Health Network, Toronto (1)  ·  Université de Sherbrooke (1)  ·  Weill Medical College of Cornell University (1)  ·  Xijing Hospital (1)

Countries

United States (5)  ·  Canada (3)  ·  Norway (2)  ·  United Kingdom (2)  ·  China (1)  ·  Greece (1)

Top investigators

Erling A Tronvik, PhD, MD (2)  ·  Ahmed A Hashem, PhD (1)  ·  Athos Patsalides, MD, MPH (1)  ·  Chadwick Prodromos, MD (1)  ·  Frederick A Lenz, MD, PhD (1)  ·  Mojgan Hodaie, MD, MSc (1)  ·  Waleed Elmallah, PhD (1)

Results publications

PMID 10916328, PMID 15793381, PMID 20006669, PMID 30734772, PMID 31342515, PMID 33384805, PMID 33990740, PMID 35162650

NIH funding

2014 (1), 2015 (1), 2016 (1)